International Conference on Autonomic Nervous System Drugs and Pharmacology

April 23-24, 2020 | USA

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program.

Spotlight

New guidelines governing the analysis of elemental impurities in pharmaceuticals are being implemented. Toxic heavy metals and residual metal catalysts may exist in the raw materials of Active Pharmaceutical Ingredients (APIs) or be added during the manufacturing process. These impurities may be a risk to human health. This white paper demonstrates that X-ray Fluorescence (XRF) is capable of performing elemental impurity analysis of the above 12 elements in various pharmaceutical materials, such as Cellulose, Talc and a Mixture of Cellulose, Talc and TiO2, by the calibration curve method using water solution standard samples, and verifying the qualification of USP .


OTHER PAST CONFERENCES

DigIT Pharma Commercial Excellence & Digital Health

September 28-29, 2022 | Germany

Future of Pharma Business: New Pharma Business Unit Opportunities – Datengetriebene Business Itelligence und Commercial Excellence in Zeiten von DIGAs,

19th Annual Pharma Data Congress

September 8-9, 2022 | UK

Showcasing success in FAIR data implementation, data analytics in drug discovery, AI/ML technologies, RWE management, data storage & infrastructure, multi-omic data integration and management

International Conference on Pain Medicine and Management

September 14-15, 2022 | USA

International Conference on Pain Medicine and Management September 19-20, 2022 Virtual Event

3rd European Congress on Pharmaceutical Science And Research

August 15-16, 2022 | Singapore

PHARMACEUTICAL SCIENCE 2022 welcomes attendees, presenters, and exhibitors from all over the world to Singapore. We are delighted to invite you all to attend and register for the “3rd European Congress on Pharmaceutical Science & Research” which is going to be held during August 15-16, 2022 in Singapore.

Spotlight

New guidelines governing the analysis of elemental impurities in pharmaceuticals are being implemented. Toxic heavy metals and residual metal catalysts may exist in the raw materials of Active Pharmaceutical Ingredients (APIs) or be added during the manufacturing process. These impurities may be a risk to human health. This white paper demonstrates that X-ray Fluorescence (XRF) is capable of performing elemental impurity analysis of the above 12 elements in various pharmaceutical materials, such as Cellulose, Talc and a Mixture of Cellulose, Talc and TiO2, by the calibration curve method using water solution standard samples, and verifying the qualification of USP .

resources